Skip to content

Clinical trials

Completed Phase 1/2 Diabetes Mellitus, Type 2 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 1/2 Status: Completed Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20042
20058
20061
20074
20084
20093
20106
20117
20124
20136
20143
20153
20173
20181
20191
20202
20224
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hanoi Medical University3
Novartis3
Novartis Pharmaceuticals3
Boston Medical Center2
Elcelyx Therapeutics, Inc.2
Fuzhou General Hospital2
Mesoblast, Ltd.2
Astellas Pharma Europe B.V.1
AstraZeneca1
Becton, Dickinson and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 268
Diabetes Mellitus18
Insulin Resistance8
Obesity5
Diabetes Mellitus, Type 12
Diabetic Nephropathies2
Inflammation2
Metabolic Diseases2
Metabolic Syndrome2
Renal Insufficiency, Chronic2

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.